Until recently, cultivated meat companies were growing meat in bioreactors designed specifically for the pharma industry, but all of that is about to change.
Workers at GOOD Meat’s pilot plant in the company’s Alameda, Calif. headquarters
The evolution of the bioreactor — the essential engine of cultivated animal protein — is approaching several critical forks.
So far, the equipment’s engineers and producers have camped on collegial common ground as the industry figures out the basics.
But soon, manufacturers, cultivated meat companies and investors will have to place their bets on the machines they think will propel the industry to market.
For now, bioreactor process is the fundamental differentiator, but other…
Join for free* to continue reading.
You’ll get access to all Alt-Meat has to offer including full access to our web content devoted to the meat alternatives market.
*Free for qualified recipients